Basic principles of cerebral protection in humans.
Lanier
W L
WL
Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000777:Anesthetics / Q000627:therapeutic use; D000818:Animals; D001463:Barbiturates / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism; D001794:Blood Pressure / Q000502:physiology; D001831:Body Temperature / Q000502:physiology; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D002545:Brain Ischemia / Q000378:metabolism / Q000503:physiopathology* / Q000517:prevention & control; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000502:physiology; D004195:Disease Models, Animal; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009553:Nimodipine / Q000627:therapeutic use; D010101:Oxygen Consumption / Q000502:physiology; D012640:Seizures / Q000503:physiopathology / Q000517:prevention & control
D000305:Adrenal Cortex Hormones; D000777:Anesthetics; D001463:Barbiturates; D001786:Blood Glucose; D002121:Calcium Channel Blockers; D018696:Neuroprotective Agents; D009553:Nimodipine